Cairo – Mubasher: Ibnsina Pharma announced that its average investments range between EGP 250-300 million per year, except for the exceptional investments in 2018 and 2019.
The company plans to inaugurate from three to four new branches every year, according to a bourse disclosure on Sunday.
It is worth noting that in 2019, Ibnsina Pharma reported net profits of EGP 328.77 million, up from EGP 262.5 million in the previous year.
